Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity
Awada, Ahmad, Dumez, Herlinde, Aftimos, Philippe G., Costermans, Jo, Bartholomeus, Sylvie, Forceville, Kathleen, Berghmans, Thierry, Meeus, Marie-Anne, Cescutti, Jessica, Munzert, Gerd, Pilz, Korinna, Liu, Dan, Schöffski, Patrick
Published in Investigational new drugs (01.06.2015)
Published in Investigational new drugs (01.06.2015)
Get full text
Journal Article
Effect of levetiracetam on cardiac repolarization in healthy subjects: A single-dose, randomized, placebo- and active-controlled, four-way crossover study
Hulhoven, Réginald, MD,PhD, Rosillon, Dominique, PhD, Bridson, William E., MD, Meeus, Marie-Anne, MD, Salas, Edubijes, BS, Stockis, Armel, PhD
Published in Clinical therapeutics (01.02.2008)
Published in Clinical therapeutics (01.02.2008)
Get full text
Journal Article
A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors
Schöffski, Patrick, Aftimos, Philippe, Dumez, Herlinde, Deleporte, Amélie, De Block, Katrien, Costermans, Jo, Billiet, Maureen, Meeus, Marie-Anne, Lee, Chooi, Schnell, David, Goeldner, Rainer-Georg, Awada, Ahmad
Published in Cancer chemotherapy and pharmacology (01.01.2016)
Published in Cancer chemotherapy and pharmacology (01.01.2016)
Get full text
Journal Article
Levocetirizine does not prolong the QT/QTc interval in healthy subjects : results from a thorough QT study
HULHOVEN, Réginald, ROSILLON, Dominique, LETIEXHE, Michel, MEEUS, Marie-Anne, DAOUST, Agnès, STOCKIS, Armel
Published in European journal of clinical pharmacology (01.11.2007)
Published in European journal of clinical pharmacology (01.11.2007)
Get full text
Journal Article
Seletracetam (UCB 44212)
Bennett, Barbara, Matagne, Alain, Michel, Philippe, Leonard, Michèle, Cornet, Miranda, Meeus, Marie-Anne, Toublanc, Nathalie
Published in Neurotherapeutics (2007)
Published in Neurotherapeutics (2007)
Get full text
Journal Article
Phase I first-in-man trial of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (Pts) with advanced solid tumors
Aftimos, Philippe Georges, Bechter, Oliver, Awada, Ahmad, Jungels, Christiane, Dumez, Herlinde, Huyvaert, Nathalie, Costermans, Jo, Lee, Chooi, Meeus, Marie-Anne, Burkard, Ute, Musa, Hanny, Zhao, Yihua, Schoffski, Patrick
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Abstract B281: Phase I study of two dosing schedules of BI 847325, an orally administered dual inhibitor of MEK and aurora kinase B, in patients with advanced solid tumors
Aftimos, Philippe, Dumez, Herlinde, Awada, Ahmad, Billiet, Maureen, Deleporte, Amélie, De Block, Katrien, Costermans, Jo, Meeus, Marie-Anne, Goeldner, Rainer-Georg, Schnell, David, Lee, Chooi, Schöffski, Patrick
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
Phase I trial of the polo-like kinase (Plk) inhibitor volasertib (BI 6727) combined with cisplatin or carboplatin in patients with advanced solid tumors
Dumez, Herlinde, Gombos, Andrea, Schöffski, Patrick, Gil, Thierry, Vulsteke, Christof, Meeus, Marie-Anne, Cescutti, Jessica, Munzert, Gerd Michael, Pilz, Korinna, Awada, Ahmad
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article